Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation

Next Previous
Trial Profile

Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BP 14979 (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Sponsors Bioprojet

Most Recent Events

  • 20 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
  • 09 Sep 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
  • 09 Apr 2014 New source identified and integrated (European Clinical Trials Database).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top